type here...

CATEGORIES

Rare and Orphan Diseases

LATEST

12Page 1 of 2

TRENDING

EDITORS CHOICE

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Gil Bashe, Medika Life Editor -
EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger

Real-World Evidence Unlocks Consumer Voice to Improve Care

Gil Bashe, Medika Life Editor -
Patient Experience is the Key to Improving Drug Development and Health Care, but Are We Listening?

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Gil Bashe, Medika Life Editor -
“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health

The Best Dating Game in Health Innovation Happens Just Off the Main Stage

Gil Bashe, Medika Life Editor -
Every January, San Francisco undergoes a transformation. For one week, the city shifts into high gear for the life sciences sector, becoming a dense,...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories